Pediatrix Medical Group, Inc. (MD)
NYSE: MD · IEX Real-Time Price · USD
8.81
0.00 (0.00%)
Apr 18, 2024, 4:00 PM EDT - Market closed
Pediatrix Medical Group Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for MD stock have an average target of 9.38, with a low estimate of 9.00 and a high estimate of 10. The average target predicts an increase of 6.47% from the current stock price of 8.81.
Analyst Consensus: Hold
* Price targets were last updated on Mar 6, 2024.
Analyst Ratings
The average analyst rating for MD stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 2 | 2 | 2 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +2.16% | Mar 6, 2024 |
| Mizuho | Mizuho | Hold Maintains $10 → $9 | Hold | Maintains | $10 → $9 | +2.16% | Feb 21, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $11 → $10 | Hold | Maintains | $11 → $10 | +13.51% | Feb 21, 2024 |
| UBS | UBS | Hold Initiates $9.5 | Hold | Initiates | $9.5 | +7.83% | Nov 30, 2023 |
| Truist Securities | Truist Securities | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +70.26% | Oct 11, 2023 |
Financial Forecast
Revenue This Year
2.10B
from 1.99B
Increased by 5.23%
Revenue Next Year
2.17B
from 2.10B
Increased by 3.38%
EPS This Year
1.28
from -0.73
EPS Next Year
1.33
from 1.28
Increased by 3.52%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 2.2B | 2.3B | 2.3B | 2.5B |
| Avg | 2.1B | 2.2B | 2.3B | 2.4B |
| Low | 2.0B | 2.0B | 2.1B | 2.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 9.0% | 7.7% | 7.0% | 9.9% |
| Avg | 5.2% | 3.4% | 4.3% | 7.8% |
| Low | -1.1% | -3.4% | -1.8% | 2.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1.38 | 1.41 | 1.43 | 1.16 |
| Avg | 1.28 | 1.33 | 1.33 | 1.13 |
| Low | 1.14 | 1.10 | 1.09 | 1.08 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 9.8% | 7.7% | -12.9% |
| Avg | - | 3.5% | - | -14.6% |
| Low | - | -14.3% | -18.0% | -18.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.